Untargeted Metabolomics Shows Alterations in Homocysteine, Lipids and Fatty Acids predicting Memory Decline in Healthy Middle-Aged Individuals
preprint
OA: closed
Abstract
INTRODUCTION Some aspects of memory start declining in the fifth decade which may be related to systemic metabolic changes. These changes have not been fully identified. This is the first Metabolome-Wide Association Study of the human plasma for the longitudinal change in memory in healthy adults. METHODS Ultra-high resolution mass spectrometry with liquid chromatography was performed on 207 University employees’ plasma. RESULTS From 10,201 measured metabolic features, 558 differed between those experiencing change vs no change in memory (False Discovery Rate, FDR< 0.2). Differentially abundant metabolites were observed in lipid and fatty acid metabolism pathways: glycerophospholipid (p=0.0003), fatty acid (p=0.0003) and linoleate (p=0.0003) pathways. Within these pathways, higher homocysteine (OR for memory decline=1.09, FDR=0.19) and lower arachidonic acid (OR=0.97, FDR=0.19), sterol (OR=0.92, FDR=0.02), acetylcholine (OR=0.78, FDR=0.19), carnitine (OR=0.75, FDR=0.19) and linoleic acid (OR=0.74, FDR=0.19) were associated memory decline. DISCUSSION Altered systemic lipid and fatty acid are linked with early memory decline in middle-aged individuals.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (39)
- doi:10.1037/0882-7974.20.1.3 via crossref
- doi:10.1177/0956797614567339 via crossref
- doi:10.1046/j.1468-1331.1999.660645.x via crossref
- doi:10.1371/journal.pone.0119452 via crossref
- doi:10.1002/elps.201400196 via crossref
- doi:10.1016/j.jpba.2014.05.023 via crossref
- doi:10.1016/j.jalz.2010.06.001 via crossref
- doi:10.1021/ac500476a via crossref
- doi:10.1093/bioinformatics/btu430 via crossref
- doi:10.1021/pr301053d via crossref
- doi:10.1093/bioinformatics/btp291 via crossref
- doi:10.1093/carcin/bgx084 via crossref
- doi:10.1152/ajpregu.00298.2016 via crossref
- doi:10.1097/acm.0b013e318217ea6c via crossref
- doi:10.1111/j.1532-5415.2010.03107.x via crossref
- doi:10.2174/156720507781788954 via crossref
- doi:10.1016/s0169-2607(03)00014-2 via crossref
- doi:10.1161/hypertensionaha.115.06277 via crossref
- doi:10.1007/s11306-011-0332-1 via crossref
- doi:10.1371/journal.pone.0108854 via crossref
- doi:10.1186/1471-2105-14-15 via crossref
- doi:10.1093/biostatistics/kxj037 via crossref
- doi:10.1093/biostatistics/kxj037 via crossref
- doi:10.1371/journal.pcbi.1003123 via crossref
- doi:10.1016/s0009-3084(00)00128-6 via crossref
- doi:10.1023/a:1011603916962 via crossref
- doi:10.1021/acs.jafc.7b03941 via crossref
- doi:10.1016/j.bbalip.2012.12.003 via crossref
- doi:10.1016/j.neuroscience.2014.09.001 via crossref
- doi:10.1016/s0304-3940(98)00209-2 via crossref
- doi:10.3402/ijch.v72i0.21162 via crossref
- doi:10.1016/j.plipres.2011.06.001 via crossref
- doi:10.1016/j.exger.2017.10.008 via crossref
- doi:10.3233/jad-150977 via crossref
- doi:10.1016/j.neurobiolaging.2006.10.013 via crossref
- doi:10.1016/j.biopha.2017.07.156 via crossref
- doi:10.1042/bj20040583 via crossref
- doi:10.3233/jad-132063 via crossref
- doi:10.1038/tp.2017.97 via crossref
Source provenance
- crossref
- last seen: 2026-05-25T01:00:08.883255+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-13T06:45:44.122212+00:00